Isosorbide mononitrate shortage

The Department of Health has notified healthcare professionals of a supply issue with all standard-release isosorbide mononitrate tablets that is expected to last until May 2013.

Isosorbide mononitrate is licensed as an adjunct in heart failure and for angina prophylaxis | SCIENCE PHOTO LIBRARY
Isosorbide mononitrate is licensed as an adjunct in heart failure and for angina prophylaxis | SCIENCE PHOTO LIBRARY

Prescribers may consider switching patients to a modified-release preparation as an alternative. 

Data on the dose equivalence of isosorbide mononitrate standard-release tablets and modified-release tablets is currently limited. Where available formulations allow, an initial mg per mg substitution (using the same overall daily dose) is advised. Further dose adjustment can be considered on an individual patient basis. 

If necessary, an unlicensed product can be supplied, although the prescriber must ensure that the prescription clearly shows this intention. 

You can find details of alternative formulations of isosorbide mononitrate licensed for the treatment of angina in an easy-to-use MIMS table.

View isosorbide mononitrate drug records

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more